ENTITY
Dechra Pharmaceuticals

Dechra Pharmaceuticals (DPH LN)

44
Analysis
Health Care • United Kingdom
Dechra Pharmaceuticals is a global specialist in the development, manufacture, and marketing of high-quality veterinary pharmaceuticals and related products, focusing on companion animals, equine, and food-producing animals. Key products include treatments for endocrinology, dermatology, and pain management, such as Vetoryl for Cushing's disease in dogs and Felimazole for hyperthyroidism in cats. The company was founded in 1997 and moved its global headquarters to Boston, Massachusetts, in June 2026.
more
•18 Jan 2024 18:40

Quiddity Leaderboard SE600 Mar 24: Two Intra-Review and 5 Regular Changes Likely

SE600 members CHR Hansen and LXI REIT could get deleted in the first quarter of 2024. Apart from that, I see five more possible index changes...

Share
bearish•Evoke
•28 Nov 2023 15:10

Quiddity Leaderboard F100/​​​250 Dec 23: Final Expectations; Two Trading Days for Announcement

Today is the base date for the December 2023 review. The index changes for the December 2023 review will be decided based on full market cap...

Share
bullish•Adevinta ASA
•15 Nov 2023 18:05

Quiddity Leaderboard SE600 Dec 23: 6 ADDs/DELs and Two Intra-Review Changes Possible

The one-way for the 6 ADDs/DELs expected for December is around US$80mn. On average, there could be around 1.6 days to buy for the 6 ADDs and 1.2...

Share
bullish•Evoke
•13 Nov 2023 18:15

Quiddity Leaderboard F100/​​​250 Dec 23: CAB Payments Could Be Deleted from F250

I suggest having a look at the 888 holdings (888 LN) / Playtech Plc (PTEC LN) pair as a sector-neutral fundamental relative value bet with a...

Share
•22 Oct 2023 07:05

Last Week In Event SPACE: Shinko Electric Industries, MGM China, Decente, Sankei Real Estate,

The weekend is here! Pour yourself a coffee, grab a comfortable seat, and sift through a brief summary of insights on various events discussed...

Logo
825 Views
Share
x